Clinical Trial Update: A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase II clinical trial update for PF-03446962 in advanced malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• PF-03446962 (PF-03446962)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Malignant Pleural Mesothelioma | Phase 2 | Status: COMPLETED